Fetal risks of maternal pharmacotherapy: Identifying signals

Gideon Koren

doi:10.1007/978-3-642-20195-0_14

Fetal risks of maternal pharmacotherapy: Identifying signals

Gideon Koren

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

15 Scopus citations

Abstract

Pregnant women may be exposed to a variety of medications that may exert toxic or teratogenic effects on the fetus. Since the thalidomide disaster, physicians and pregnant women tend to withhold medications during pregnancy, although the risk of teratogenic effect from most drugs in therapeutic doses is nonexistent. This chapter will review the principles of teratology and the pharmacoepidemiological evidence for drug safety/risk in human gestation.

Original language	English
Title of host publication	Pediatric Clinical Pharmacology
Editors	Hannsjorg Seyberth, Hannsjorg Seyberth, Matthias Schwab, Matthias Schwab, Anders Rane
Pages	285-294
Number of pages	10
DOIs	https://doi.org/10.1007/978-3-642-20195-0_14
State	Published - 2011
Externally published	Yes

Publication series

Name	Handbook of Experimental Pharmacology
Volume	205
ISSN (Print)	0171-2004
ISSN (Electronic)	1865-0325

Keywords

Bias
Drugs
Fetal safety
Fetus
Teratogenicity
Teratology

Access to Document

10.1007/978-3-642-20195-0_14

Cite this

@inbook{f4b810fa71df46a293b37dbf7ea177cc,

title = "Fetal risks of maternal pharmacotherapy: Identifying signals",

abstract = "Pregnant women may be exposed to a variety of medications that may exert toxic or teratogenic effects on the fetus. Since the thalidomide disaster, physicians and pregnant women tend to withhold medications during pregnancy, although the risk of teratogenic effect from most drugs in therapeutic doses is nonexistent. This chapter will review the principles of teratology and the pharmacoepidemiological evidence for drug safety/risk in human gestation.",

keywords = "Bias, Drugs, Fetal safety, Fetus, Teratogenicity, Teratology",

author = "Gideon Koren",

year = "2011",

doi = "10.1007/978-3-642-20195-0_14",

language = "אנגלית",

isbn = "9783642201943",

series = "Handbook of Experimental Pharmacology",

pages = "285--294",

editor = "Hannsjorg Seyberth and Hannsjorg Seyberth and Matthias Schwab and Matthias Schwab and Anders Rane",

booktitle = "Pediatric Clinical Pharmacology",

}

TY - CHAP

T1 - Fetal risks of maternal pharmacotherapy

T2 - Identifying signals

AU - Koren, Gideon

PY - 2011

Y1 - 2011

N2 - Pregnant women may be exposed to a variety of medications that may exert toxic or teratogenic effects on the fetus. Since the thalidomide disaster, physicians and pregnant women tend to withhold medications during pregnancy, although the risk of teratogenic effect from most drugs in therapeutic doses is nonexistent. This chapter will review the principles of teratology and the pharmacoepidemiological evidence for drug safety/risk in human gestation.

AB - Pregnant women may be exposed to a variety of medications that may exert toxic or teratogenic effects on the fetus. Since the thalidomide disaster, physicians and pregnant women tend to withhold medications during pregnancy, although the risk of teratogenic effect from most drugs in therapeutic doses is nonexistent. This chapter will review the principles of teratology and the pharmacoepidemiological evidence for drug safety/risk in human gestation.

KW - Bias

KW - Drugs

KW - Fetal safety

KW - Fetus

KW - Teratogenicity

KW - Teratology

UR - http://www.scopus.com/inward/record.url?scp=80054917401&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-20195-0_14

DO - 10.1007/978-3-642-20195-0_14

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

C2 - 21882117

AN - SCOPUS:80054917401

SN - 9783642201943

T3 - Handbook of Experimental Pharmacology

SP - 285

EP - 294

BT - Pediatric Clinical Pharmacology

A2 - Seyberth, Hannsjorg

A2 - Schwab, Matthias

A2 - Rane, Anders

ER -

Fetal risks of maternal pharmacotherapy: Identifying signals

Abstract

Publication series

Keywords

Access to Document

Other files and links

Fingerprint

Cite this